Dr. Krzysztof (Krys) Bojanowski is the CEO of Sunny BioDiscovery, Inc., a California – based biotech lab engaged in skin longevity research. Krys received his PhD cum laude in Cellular and Molecular Pharmacology at the University of Paris, France, then, for 8 years studied angiogenesis and cancer at the National Cancer Center in Tokyo, Harvard Medical School and Lawrence Berkeley National Laboratory. Started in 2000, his company, Sunny BioDiscovery, developed a line of award-winning products for diabetic skin and wounds with the support from 4 NIH Institutes, including the National Institute on Aging. His scientific interests focus on the importance of dermal-hypodermal junction, hypodermis and its stem cells for dermal regeneration. Krys' lab also engages in contract research projects with cosmetic and biotech companies.